Skip to content

Company information lookup

CYNATA THERAPEUTICS LIMITED (CYP)

Stem cell and regenerative medicine development.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
CYP 0.385 6.94% 0.365 0.385 0.360 0.385 0.350 59,208

CYNATA THERAPEUTICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code CYP
Securities
Official Listing Date 20 December, 2007
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.cynata.com
Registered Office Address Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3143
Head Office Telephone (03) 9824 5254
Head Office Fax (03) 9822 7735
Share Registry SECURITY TRANSFER REGISTRARS PTY. LIMITED
770 CANNING HIGHWAY, APPLECROSS, WA, AUSTRALIA, 6153
Share Registry Telephone (08) 9315 2333
Directors / Senior Management
Dr Stewart Washer (Executive Chairman)
Dr Ross Macdonald (Managing Director, CEO)
Mr Howard Digby (Non Exec. Director)
Mr Peter Webse (Non Exec. Director)
Company Secretary Mr Peter Webse
Principal Activities Stem cell and regenerative medicine development.

CYNATA THERAPEUTICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
31/10/2014 asterix Activity Report & Appendix 4C 7 PDF
27/10/2014   BBY Initiates Cynata Research Coverage 1 PDF
23/10/2014   Cynata to Appoint Dr John Chiplin to Board of Directors 2 PDF
22/10/2014   Section 708A Notice 1 PDF
22/10/2014   Appendix 3B-Exercise of Listed Options 12 PDF
16/10/2014   Annual Report to shareholders 68 PDF
16/10/2014   Notice of Annual General Meeting/Proxy Form 19 PDF
26/09/2014   Appendix 3B - Exercise of Listed Options 12 PDF
26/09/2014   Section 708A Notice 1 PDF
18/09/2014 asterix Cynata Announces Landmark Licensing Deal 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
31 Oct 2014 0.385 6.94% 0.385 0.350 59,208
30 Oct 2014 0.360 0% 0.370 0.350 54,040
28 Oct 2014 0.360 -4% 0.385 0.360 33,280
27 Oct 2014 0.375 0% 0.375 0.375 30,053
24 Oct 2014 0.375 -1.32% 0.390 0.375 75,852

* Volume of shares shown represents only those shares traded on ASX.

CYNATA THERAPEUTICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security CYP. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security CYP

Warrants & Structured Products

No warrants & Structured Products are available over the security CYP